Croda International (DB:6CMB) - Stock Price, News & Analysis

6CMB Stock Overview

Engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. More details

6CMB fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	1/6
Past Performance	2/6
Financial Health	6/6
Dividends	4/6

Rewards

Earnings are forecast to grow 15.12% per year

Analysts in good agreement that stock price will rise by 31%

Risk Analysis

Dividend of 3.15% is not well covered by earnings

Croda International Plc Competitors

Evonik Industries

XTRA:EVK

€8.1b

Wacker Chemie

XTRA:WCH

€3.6b

Symrise

XTRA:SY1

€14.6b

AlzChem Group

XTRA:ACT

€608.5m

Price History & Performance

Summary of all time highs, changes and price drops for Croda International
Historical stock prices
Current Share Price	UK£41.93
52 Week High	UK£60.00
52 Week Low	UK£41.42
Beta	0.78
11 Month Change	-5.46%
3 Month Change	-8.95%
1 Year Change	-19.37%
33 Year Change	-63.88%
5 Year Change	-28.75%
Change since IPO	375.00%

Recent updates

Shareholder Returns

	6CMB	DE Chemicals	DE Market
7D	-1.9%	-1.3%	-1.3%
1Y	-19.4%	-1.6%	7.4%

Return vs Industry: 6CMB underperformed the German Chemicals industry which returned -1.2% over the past year.

Return vs Market: 6CMB underperformed the German Market which returned 7.1% over the past year.

Price Volatility

Is 6CMB's price volatile compared to industry and market?
6CMB volatility
6CMB Average Weekly Movement	4.8%
Chemicals Industry Average Movement	4.2%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.8%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 6CMB has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 6CMB's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1925	5,852	Steve Foots	www.croda.com

Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations.

Croda International Plc Fundamentals Summary

How do Croda International's earnings and revenue compare to its market cap?
6CMB fundamental statistics
Market cap	€5.81b
Earnings (TTM)	€195.50m
Revenue (TTM)	€1.96b

29.7x

P/E Ratio

3.0x

P/S Ratio

Is 6CMB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6CMB income statement (TTM)
Revenue	UK£1.63b
Cost of Revenue	UK£914.80m
Gross Profit	UK£714.70m
Other Expenses	UK£552.00m
Earnings	UK£162.70m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 25, 2025

Earnings per share (EPS)	1.17
Gross Margin	43.86%
Net Profit Margin	9.98%
Debt/Equity Ratio	27.2%

How did 6CMB perform over the long term?

See historical performance and comparison

Dividends

3.1%

Current Dividend Yield

93%

Payout Ratio

6CMB Stock Overview

Rewards

Risk Analysis

Croda International Plc Competitors

XTRA:EVK

€8.1b

XTRA:WCH

€3.6b

XTRA:SY1

€14.6b

XTRA:ACT

€608.5m

Price History & Performance

Recent News & Updates

Croda International plc Announces Directorate Change

Upcoming dividend of UK£0.47 per share

First half dividend of UK£0.47 announced

First half 2024 earnings released: EPS: UK£0.57 (vs UK£0.63 in 1H 2023)

Stephen Oxley to Join Croda International plc as Executive Director No Later Than 1 April 2025

High number of new directors

Recent updates

Croda International plc Announces Directorate Change

Upcoming dividend of UK£0.47 per share

First half dividend of UK£0.47 announced

First half 2024 earnings released: EPS: UK£0.57 (vs UK£0.63 in 1H 2023)

Stephen Oxley to Join Croda International plc as Executive Director No Later Than 1 April 2025

High number of new directors

Croda International Plc Appoints Ian Bull as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees

Croda International plc Appoints Ian Bull as A Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees

Croda International Plc Declares Final Dividend

Upcoming dividend of UK£0.62 per share

Now 23% overvalued after recent price rise

Croda International plc Recommends Final Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on 29 May 2024

Final dividend of UK£0.62 announced

Full year 2023 earnings released: EPS: UK£1.23 (vs UK£4.66 in FY 2022)

Less than half of directors are independent

Now 22% overvalued after recent price rise

Croda International Plc to Report First Half, 2024 Results on Jul 30, 2024

Croda International plc Announces Louisa Burdett, Chief Financial Officer, Intends to Leave in June 2024

Group Chief Scientific Officer recently sold €23m worth of stock

Croda International Plc, Annual General Meeting, Apr 24, 2024

Upcoming dividend of UK£0.47 per share at 2.0% yield

New minor risk - Profit margin trend

First half 2023 earnings released: EPS: UK£0.63 (vs UK£3.90 in 1H 2022)

Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370).

Investor sentiment deteriorates as stock falls 15%

President of Corporate Development recently sold €238k worth of stock

Upcoming dividend of UK£0.61 per share at 1.5% yield

Executive Director recently sold €553k worth of stock

President of Regional Delivery recently sold €655k worth of stock

Full year 2022 earnings released: EPS: UK£4.66 (vs UK£2.30 in FY 2021)

Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion.

Independent Non-Executive Director recently bought €61k worth of stock

Croda International plc Announces Directorate Changes

Upcoming dividend of UK£0.47 per share

First half 2022 earnings released

Croda International Plc Announces Interim Dividend, Payable October 4, 2022

Croda International Plc Announces Board and Committee Changes

Cargill, Incorporated completed the acquisition of 77% stake in Performance Technologies and Industrial Chemicals Businesses from Croda International Plc (LSE:CRDA).

Now 23% undervalued after recent price drop

Croda International plc Announces Final Dividend for the Financial Year Ended 31 December 2021

Upcoming dividend of UK£0.56 per share

Key Executive recently sold €588k worth of stock

Insider recently sold €119k worth of stock

Croda International Plc to Report Fiscal Year 2022 Results on Mar 07, 2023

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Croda International plc Recommends Final Dividend for the Year Ended December 31, 2021, Payable on June 6, 2022

Cargill Velocity Holdings Limited agreed to acquire an unknown majority stake in Bio-based industrial business from Croda International Plc (LSE:CRDA) for an enterprise value of approximately €920 million.

Insider recently sold €241k worth of stock

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of UK£0.43 per share

President of Performance Technologies recently sold €812k worth of stock

Non-Executive Director recently sold €2.0m worth of stock

First half 2021 earnings released: EPS UK£1.10 (vs UK£0.84 in 1H 2020)

Croda International plc Declares Final Dividend

Group Chief Scientific Officer recently sold €771k worth of stock

President of Consumer Care recently sold €272k worth of stock

Upcoming dividend of UK£0.52 per share